Skip to main content
. 2019 Sep 18;19:824. doi: 10.1186/s12879-019-4425-1

Table 2.

Gynaecologic status per study groups at enrolment

Variables Overall Group 1
Healthy + probiotic
Group 2
BV + antibiotic + probiotic
Group 3
BV antibiotic
No. of enrolment 39 13 12 14
Currently have vaginal abnormal dischargea
 No (%) 25 (64.10) 12 (92.31) 6 (50.00) 7 (50.00)
 Yes (%) 14 (35.90) 1 (7.69) 6 (50.00) 7 (50.00)
Participant currently has fishy-smelling abnormal discharge
 No (%) 34 (87.18) 12 (92.31) 11 (91.67) 11 (78.57)
 Yes (%) 5 (12.82) 1 (7.69) 1 (8.33) 3 (21.43)
Have you been treated for STIs in last 12 months
 No (%) 34 (89.47) 11 (84.62) 10 (90.91) 13 (92.86)
 Yes (%) 4 (10.53) 2 (15.38) 1 (9.09) 1 (7.14)
Ever treated for BV in the last 12 months
 No (%) 37 (94.87) 13 (100.0) 10 (83.33) 14 (100.0)
 Yes (%) 2 (5.13) 0 (0.00) 2 (16.67) 0 (0.00)
Age of debut sex
 < 16 years (%) 5 (12.82) 3 (23.08) 0 (0.00) 2 (14.29)
 ≥ 16 years (%) 34 (87.18) 10 (76.92) 12 (100.0) 12 (85.71)
Current male partners
 < 2 (%) 33 (84.62) 12 (92.31) 11 (91.67) 10 (71.43)
 ≥ 2 (%) 6 (15.38) 1 (7.69) 1 (8.33) 4 (28.57)
Male partners in the last 12 months
 < 2 (%) 26 (66.67) 9 (69.23) 7 (58.33) 10 (71.43)
 ≥ 2 (%) 13 (33.33) 4 (30.77) 5 (41.67) 4 (28.57)
New male partners in the last 12 months
 < 2 (%) 35 (89.74) 12 (92.31) 11 (91.67) 12 (85.71)
 ≥ 2 (%) 4 (10.26) 1 (7.69) 1 (8.33) 2 (14.29)
Condom use in the last 12 months
 Always (%) 6 (15.38) 2 (15.38) 2 (16.67) 2 (14.29)
 Never (%) 12 (30.77) 6 (46.15) 4 (33.33) 2 (14.29)
 Sometimes (%) 21 (53.85) 5 (38.46) 6 (50.00) 10 (71.43)
Do you practice vaginal douching
 No (%) 39 (100.0) 13 (100.0) 12 (100.0) 14 (100.0)
 Yes (%) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
Use soap to wash vagina to make it smell good?
 No (%) 22 (56.41) 8 (61.54) 10 (83.33) 4 (28.57)
 Yes (%) 17 (43.59) 5 (38.46) 2 (16.67) 10 (71.43)
Buds and/or hyphae (yeast)
 Negative (%) 36 (92.31) 12 (92.31) 11 (91.67) 13 (92.86)
 Positive (%) 3 (7.69) 1 (7.69) 1 (8.33) 1 (7.14)
vaginal sex in a week for the last 12 months
 0–3 times (%) 30 (83.33) 12 (92.31) 10 (100.0) 8 (61.54)
 > 3 times (%) 6 (16.67) 1 (7.69) 0 (0.00) 5 (38.46)
Continuing to use injectable contraceptives
 No (%) 2 (5.41) 1 (8.33) 1 (8.33) 0 (0.00)
 Yes (%) 35 (94.59) 11 (91.67) 11 (91.67) 13 (100.0)

a Group 2 and 3 participants were significantly more likely (p = 0.0001) to have vaginal abnormal discharge compared to Group 1 participants